Stock Scorecard



Stock Summary for Collegium Pharmaceutical Inc (COLL) - $40.91 as of 3/28/2024 3:50:41 PM EST

Total Score

14 out of 29

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for COLL

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for COLL

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for COLL

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for COLL

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for COLL

Collegium Pharmaceutical ( NASDAQ:COLL ) Upgraded to Strong-Buy at StockNews.com 3/22/2024 9:48:00 AM
Humana ( HUM ) , DUOS Unveil Program to Improve Veterans' Health 3/21/2024 5:39:00 PM
Are Investors Undervaluing Collegium Pharmaceutical ( COLL ) Right Now? 3/18/2024 1:40:00 PM
Strength Seen in Aquestive Therapeutics ( AQST ) : Can Its 16.0% Jump Turn into More Strength? 3/18/2024 10:46:00 AM
Time to Get These 5 Top Relative Price Strength Stocks 3/15/2024 10:39:00 AM
3 Reasons Why Collegium Pharmaceutical ( COLL ) Is a Great Growth Stock 3/13/2024 4:45:00 PM
Encompass Health ( EHC ) , Piedmont to Build Loganville Facility 3/11/2024 4:46:00 PM
Organon Shows Rising Price Performance With Jump To 81 RS Rating 3/11/2024 8:00:00 AM
Humana ( HUM ) Inks Value-Based Deal to Offer Better Kidney Care 3/6/2024 5:44:00 PM
Here's Why You Should Invest in Aldeyra ( ALDX ) Stock Now 3/6/2024 2:40:00 PM

Financial Details for COLL

Company Overview

Ticker COLL
Company Name Collegium Pharmaceutical Inc
Country USA
Description Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications. The company is headquartered in Stoughton, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/2/2024

Stock Price History

Last Day Price 40.91
Last Day Price Updated 3/28/2024 3:50:41 PM EST
Last Day Volume 362,415
Average Daily Volume 512,873
52-Week High 40.91
52-Week Low 20.83
Last Price to 52 Week Low 96.40%

Valuation Measures

Trailing PE 31.52
Industry PE 100.07
Sector PE 60.76
5-Year Average PE 22.30
Free Cash Flow Ratio 3.38
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 1.17
Total Cash Per Share 12.11
Book Value Per Share Most Recent Quarter 6.13
Price to Book Ratio 6.53
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 2.29
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 31,959,800
Market Capitalization 1,307,475,418
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 5,198.00%
Annual Earnings Growth 292.60%
Reported EPS 12 Trailing Months 1.29
Reported EPS Past Year 1.18
Reported EPS Prior Year 0.56
Net Income Twelve Trailing Months 48,155,000
Net Income Past Year 48,155,000
Net Income Prior Year -25,002,000
Quarterly Revenue Growth YOY 15.50%
5-Year Revenue Growth -3.18%

Balance Sheet

Total Cash Most Recent Quarter 386,878,000
Total Cash Past Year 386,878,000
Total Cash Prior Year 173,688,000
Net Cash Position Most Recent Quarter -280,293,000
Net Cash Position Past Year -280,293,000
Long Term Debt Past Year 667,171,000
Long Term Debt Prior Year 700,951,000
Total Debt Most Recent Quarter 667,171,000
Equity to Debt Ratio Past Year 0.23
Equity to Debt Ratio Most Recent Quarter 0.23
Total Stockholder Equity Past Year 195,431,000
Total Stockholder Equity Prior Year 194,842,000
Total Stockholder Equity Most Recent Quarter 195,431,000

Options

Put/Call Ratio 0.08
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 1.34
MACD Signal 1.26
20-Day Bollinger Lower Band 23.73
20-Day Bollinger Middle Band 32.73
20-Day Bollinger Upper Band 41.72
Beta 1.01
RSI 66.33
50-Day SMA 26.40
200-Day SMA 21.97

System

Modified 3/27/2024 9:46:26 PM EST